World's Best Scientists 2026 revealed!
Riccardo Lencioni

Riccardo Lencioni

D-Index & Metrics

Medicine

D-Index
89
Citations
58088
World Ranking
12411
National Ranking
469

Overview

Riccardo Lencioni is affiliated with the University of Pisa in Italy and has contributed extensively to research in the field of medicine, with a particular focus on hepatology. Their work spans various subfields including radiology, nuclear medicine, imaging, pulmonary and respiratory medicine, cardiology and cardiovascular medicine, as well as oncology.

The scientist has published a significant number of papers dealing with hepatocellular carcinoma treatment and prognosis, lung cancer treatments and mutations, colorectal cancer studies, cancer mechanisms and therapy, cardiomyopathy and myosin studies, renal cell carcinoma treatment, and liver disease diagnosis and treatment.

Recent notable publications by Riccardo Lencioni include:

  • EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization, 2024, Journal of Clinical Oncology

While many frequently cited papers in the domain of hepatocellular carcinoma are authored by Josep M. Llovet, they reflect the core scientific conversations within the same field in which Lencioni has contributed. Some important papers related to this subject include:

  • Hepatocellular carcinoma, 2021, Nature Reviews Disease Primers
  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma, 2021, Nature Reviews Gastroenterology & Hepatology
  • mRECIST for HCC: Performance and novel refinements, 2020, Journal of Hepatology
  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference, 2020, Hepatology

Riccardo Lencioni has collaborated frequently with a number of researchers, including:

  • Masatoshi Kudo
  • Dania Cioni
  • Emanuele Neri
  • Richard S. Finn
  • Bruno Sangro

The scientist's publications are often found in specific medical and oncological journals, with multiple works in the following venues:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Journal of Hepatology
  • Diagnostics
  • Journal of Vascular and Interventional Radiology

Lencioni's research predominantly addresses issues related to the diagnosis and treatment of liver cancer and related diseases, integrating imaging techniques and molecular therapies. Their work contributes to the understanding of cancer mechanisms and therapeutic approaches in hepatology and oncology broadly.

Best Publications

  • Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

  • Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

    Riccardo Antonio Lencioni;Jm Llovet;Jm Llovet

  • Hepatocellular carcinoma.

    Josep M Llovet;Robin Kate Kelley;Augusto Villanueva;Amit G Singal

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

    Johannes Lammer;Katarina Malagari;Thomas Vogl;Frank Pilleul

  • Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

    Riccardo A. Lencioni;Hans Peter Allgaier;Dania Cioni;Manfred Olschewski

  • Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update

    Muneeb Ahmed;Luigi Solbiati;Christopher L. Brace;David J. Breen

  • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008

    M. Claudon;D. Cosgrove;T. Albrecht;L. Bolondi

  • Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation

    Riccardo Lencioni;Dania Cioni;Laura Crocetti;Chiara Franchini

  • Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

    Jeong Heo;Tony Reid;Leyo Ruo;Caroline J. Breitbach

  • Guidelines for the Use of Contrast Agents in Ultrasound - January 2004

    T Albrecht;M Blomley;L Bolondi;M Claudon

  • Local-Regional Treatment of Hepatocellular Carcinoma

    Riccardo Antonio Lencioni;Laura Crocetti

  • Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply.

    Sandro Rossi;Francesco Garbagnati;Riccardo Lencioni;Hans-Peter Allgaier

  • Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.

    Riccardo Lencioni;Josep M. Llovet;Guohong Han;Won Young Tak

  • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

    J.-L. Raoul;B. Sangro;A. Forner;V. Mazzaferro

  • Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.

    Riccardo Lencioni;Thierry de Baere;Michael C. Soulen;William S. Rilling

  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

    Josep M. Llovet;Josep M. Llovet;Thierry De Baere;Thierry De Baere;Laura Kulik;Philipp K. Haber

  • Loco-regional treatment of hepatocellular carcinoma.

    Riccardo Lencioni

  • The Etiology of Hepatocellular Carcinoma and Consequences for Treatment

    Arun J. Sanyal;Seung Kew Yoon;Riccardo Lencioni

  • Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)

    Riccardo Lencioni;Laura Crocetti;Roberto Cioni;Robert Suh

Frequent Co-Authors

Masatoshi Kudo
Masatoshi Kudo Kindai University
Thomas J. Vogl
Thomas J. Vogl Goethe University Frankfurt
Josep M. Llovet
Josep M. Llovet University of Barcelona
Alan P. Venook
Alan P. Venook University of California, San Francisco
Johannes Lammer
Johannes Lammer Medical University of Vienna
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Tadatoshi Takayama
Tadatoshi Takayama Nihon University
Thierry de Baere
Thierry de Baere Institut Gustave Roussy
Luigi Bolondi
Luigi Bolondi University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean becoming a doctor. The healthcare field offers many alternative paths, some of which can be pursued online. For those interested in leadership and organizational roles within hospitals or healthcare facilities, healthcare administration programs provide strong management foundations and can lead to roles in hospital management or health services administration.

Nurses looking to advance their clinical expertise can consider adn to fnp programs, which offer efficient pathways from an associate degree in nursing to a family nurse practitioner credential.

For those passionate about diet, wellness, and supporting public health, earning an online degree nutrition can open doors to roles in dietetics, nutrition counseling, or health education.

Accreditation is especially important in healthcare education. If you’re considering a master’s-level qualification, it’s worth exploring which online healthcare degree programs are recognized for their accreditation by cahme? Accredited programs help ensure your degree meets rigorous industry standards, boosting employability.

Best Scientists Citing Riccardo Lencioni

Trending Scientists

Recently Published Articles